South Korea · Series D startup

Who invested in 1st Biotherapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$22Mraised across 1 round since 2026, from 1 source

Latest round
Series D, $22MJan 2026
Investors
2
See who backed them

The rounds

  1. Jan 2026

Founders and team

From 1st Biotherapeutics's own website: 2 on the team.

  • Brian YoungHoon KimChief Financial Officer
  • David KimChief Business Officer

Everyone who backed them

Smilegate InvestmentGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about 1st Biotherapeutics

Who invested in 1st Biotherapeutics?

1st Biotherapeutics's investors include Smilegate Investment and Shinhan Venture Investment.

How much has 1st Biotherapeutics raised?

1st Biotherapeutics has raised $22M across 1 round since 2026.

When did 1st Biotherapeutics last raise?

1st Biotherapeutics's most recent round was a Series D of $22M in Jan 2026.

What was 1st Biotherapeutics's biggest round?

Its most recent round, $22M in Jan 2026, is also its largest on record.

Who backed 1st Biotherapeutics first?

1st Biotherapeutics's first round on record, in Jan 2026, was backed by Smilegate Investment and Shinhan Venture Investment.

What stage is 1st Biotherapeutics at?

1st Biotherapeutics's latest named round is a Series D, in Jan 2026.

Where is 1st Biotherapeutics based?

1st Biotherapeutics is based in South Korea.

Companies like 1st Biotherapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.